{
    "2019-01-21": [
        [
            {
                "time": "2023-03-15",
                "original_text": "AbbVie's Imbruvica Fails in Phase III Pancreatic Cancer Study",
                "features": {
                    "keywords": [
                        "AbbVie",
                        "Imbruvica",
                        "Phase III",
                        "Pancreatic Cancer",
                        "Study"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2023-03-15",
                "original_text": "What's in Store for Bristol-Myers (BMY) in Q4 Earnings?",
                "features": {
                    "keywords": [
                        "Bristol-Myers",
                        "Q4",
                        "Earnings"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-03-15",
                "original_text": "Zacks Value Trader Highlights: Crocs, Five Below, AbbVie and J.Jill",
                "features": {
                    "keywords": [
                        "Zacks",
                        "Value Trader",
                        "Crocs",
                        "Five Below",
                        "AbbVie",
                        "J.Jill"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "retail",
                        "healthcare",
                        "consumer goods"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}